Moreover, a number of studies have highlighted a link between leptin and the leptin receptor (Ob-R) overexpression with more aggressive breast cancer as evidenced by distant metastases, lymph node metastases, and increased tumor size [10,17]. Here, LEPR is linked to breast carcinoma.